DALLAS--(BUSINESS WIRE)--Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment...
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska...
SAN JOSE, Calif.--(BUSINESS WIRE)--Join AI leaders, innovators, and solutions providers as we explore how artificial intelligence is shaping the future of healthcare at The...
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold...
IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced today that remdesivir, an anti-viral agent used in the treatment of COVID, now tops its list of drugs by...
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
